搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
elvn
/
财务摘要
Enliven Therapeutics Inc
ELVN
添加自选
58.810
USD
+0.750
+1.29%
收盘 08-14 16:00(美东)
报价延迟15分钟
58.820
USD
+58.820
盘后交易 08/14, 20:00 (美东)
4.31B
总市值
亏损
市盈率 TTM
Enliven Therapeutics Inc
58.810
+0.750
+1.29%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
ELVN 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Enliven Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
Enliven Therapeutics Inc 财报日历
最新发布
8月 5, 2026
每股收益 / 预测值
-0.49
/-0.40
营业收入 / 预测值
--
/0.00
查看即将公布的财报 >>
报告期
FY2025 财报
营业收入(YoY)
--
--
每股收益(YoY)
-1.83
3.24%
分析师评级
BUY
2026/08/14
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-0.96%
-0.49
34.03%
-0.38
-2.51%
-0.48
32.36%
-0.32
-17.17%
-0.49
-5.46%
-0.57
1.18%
-0.46
5.22%
-0.48
-1.66%
-0.41
32.00%
-0.54
-109.60%
-0.47
--
-0.51
--
-0.41
--
-0.80
--
4.90
--
--
--
--
--
--
--
--
--
--
净利润
-28.22%
-32.48M
17.23%
-23.63M
-27.99%
-29.67M
12.99%
-20.15M
-26.99%
-25.34M
-25.53%
-28.54M
-19.67%
-23.18M
-11.49%
-23.16M
-19.31%
-19.95M
-54.43%
-22.74M
-160.18%
-19.37M
-350.62%
-20.77M
-46.05%
-16.72M
-0.58%
-14.72M
324.77%
32.19M
66.23%
-4.61M
13.01%
-11.45M
-42.72%
-14.64M
-24.32%
-14.32M
-9.85%
-13.65M
资产负债率
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
--
--
--
--
--
--
--
--
--
利润表
营业利润
-30.17%
-37.21M
12.21%
-27.82M
-27.47%
-34.28M
7.29%
-25.10M
-16.18%
-28.58M
-21.96%
-31.69M
-18.33%
-26.90M
-11.63%
-27.07M
-22.20%
-24.60M
-58.28%
-25.99M
-597.85%
-22.73M
-401.93%
-24.25M
-74.76%
-20.13M
-11.98%
-16.42M
77.28%
-3.26M
64.63%
-4.83M
12.51%
-11.52M
-42.62%
-14.66M
-24.10%
-14.33M
-9.32%
-13.66M
净利润
-28.22%
-32.48M
17.23%
-23.63M
-27.99%
-29.67M
12.99%
-20.15M
-26.99%
-25.34M
-25.53%
-28.54M
-19.67%
-23.18M
-11.49%
-23.16M
-19.31%
-19.95M
-54.43%
-22.74M
-160.18%
-19.37M
-350.62%
-20.77M
-46.05%
-16.72M
-0.58%
-14.72M
324.77%
32.19M
66.23%
-4.61M
13.01%
-11.45M
-42.72%
-14.64M
-24.32%
-14.32M
-9.85%
-13.65M
资产负债表
流动资产
83.07%
907.34M
57.36%
463.14M
49.27%
474.88M
62.52%
482.68M
55.79%
495.62M
-12.72%
294.32M
19.53%
318.13M
10.57%
297.00M
12.34%
318.13M
13.15%
337.20M
196.92%
266.15M
354.46%
268.61M
340.70%
283.18M
279.49%
298.00M
-3.30%
89.64M
-44.24%
59.10M
-9.95%
64.26M
-2.28%
78.53M
2.53%
92.70M
6.30%
106.00M
流动负债总额
-6.90%
14.16M
-17.79%
11.49M
4.10%
16.57M
-13.96%
14.65M
-31.19%
15.21M
-44.18%
13.97M
-38.54%
15.91M
40.96%
17.03M
141.66%
22.11M
128.76%
25.03M
1314.97%
25.89M
564.41%
12.08M
177.01%
9.15M
51.49%
10.94M
-74.62%
1.83M
-74.71%
1.82M
-52.65%
3.30M
31.26%
7.22M
15.42%
7.21M
35.37%
7.19M
总资产
80.64%
910.22M
53.63%
464.85M
46.17%
476.17M
60.72%
490.88M
54.07%
503.89M
-11.73%
302.57M
19.82%
325.76M
11.45%
305.43M
13.36%
327.04M
13.18%
342.78M
195.64%
271.87M
363.66%
274.04M
346.14%
288.50M
271.15%
302.87M
-1.80%
91.96M
-44.78%
59.10M
-10.77%
64.67M
-0.10%
81.60M
3.09%
93.65M
6.84%
107.03M
总负债
-2.21%
15.07M
-19.53%
11.49M
4.10%
16.57M
-13.36%
14.75M
-30.28%
15.41M
-43.05%
14.27M
-38.70%
15.91M
38.51%
17.03M
132.58%
22.11M
118.91%
25.07M
1318.63%
25.96M
576.18%
12.29M
187.92%
9.51M
24.59%
11.45M
-75.97%
1.83M
-76.25%
1.82M
-55.98%
3.30M
50.83%
9.19M
18.87%
7.62M
39.75%
7.65M
总权益
83.25%
895.15M
57.26%
453.37M
48.33%
459.60M
65.09%
476.12M
60.19%
488.47M
-9.26%
288.30M
26.00%
309.85M
10.18%
288.40M
9.30%
304.93M
9.02%
317.71M
172.84%
245.91M
356.91%
261.75M
354.65%
278.99M
302.44%
291.42M
4.76%
90.13M
-42.35%
57.29M
-5.55%
61.36M
-4.21%
72.41M
1.89%
86.03M
4.94%
99.37M
现金流量表
经营净额
-8.64%
-18.53M
20.04%
-19.29M
7.93%
-15.84M
-8.91%
-13.28M
16.53%
-17.06M
-3.28%
-24.13M
-37.82%
-17.20M
23.29%
-12.19M
-69.60%
-20.43M
-12.08%
-23.36M
-563.94%
-12.48M
-278.34%
-15.89M
2.26%
-12.05M
-21.47%
-20.84M
84.94%
-1.88M
61.46%
-4.20M
-18.93%
-12.33M
-31.80%
-17.16M
-50.99%
-12.48M
-5.36%
-10.90M
投资净额
-140.52%
-441.57M
2880.10%
42.53M
1602.75%
12.38M
-127.37%
-4.06M
-445.34%
-183.59M
107.98%
1.43M
-98.12%
727.00K
141.71%
14.83M
77.78%
-33.66M
-57593.55%
-17.89M
-7.49%
38.69M
-254.00%
-35.55M
-2514.24%
-151.52M
-100.58%
-31.00K
388.59%
41.82M
361.37%
23.08M
85.24%
6.28M
-70.85%
5.33M
-168.32%
-14.49M
14.10%
-8.83M
融资净额
112.21%
463.42M
4196.15%
10.05M
-98.44%
623.00K
-132.95%
-368.00K
11991.81%
218.38M
-99.74%
234.00K
44313.33%
39.97M
362.82%
1.12M
164.04%
1.81M
-61.98%
90.27M
107.30%
90.00K
--
-425.00K
--
-2.82M
--
237.44M
-12230.00%
-1.23M
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-101.68%
-10.00K
34708.15%
46.99M
常见问题
Enliven Therapeutics Inc的流动资产是多少?
根据Enliven Therapeutics Inc的FY2025财报,流动资产为474.88M(同比变化49.27)。
Enliven Therapeutics Inc的总资产是多少?
根据Enliven Therapeutics Inc的FY2025财报,Enliven Therapeutics Inc的总资产为476.17M(同比变化46.17)。
Enliven Therapeutics Inc的总负债是多少?
根据Enliven Therapeutics Inc的FY2025财报,Enliven Therapeutics Inc的总负债为16.57M(同比变化4.10)。
Enliven Therapeutics Inc的总权益是多少?
根据Enliven Therapeutics Inc的FY2025财报,Enliven Therapeutics Inc的总权益为459.60M(同比变化48.33)。
Enliven Therapeutics Inc的净营业收入是多少?
根据Enliven Therapeutics Inc的FY2025财报,Enliven Therapeutics Inc的净营业收入为-119.66M(同比变化-14.45)。
Enliven Therapeutics Inc的净投资是多少?
根据Enliven Therapeutics Inc的FY2025财报,Enliven Therapeutics Inc的净投资为-173.84M(同比变化-382.93)。
Enliven Therapeutics Inc的净融资是多少?
根据Enliven Therapeutics Inc的FY2025财报,Enliven Therapeutics Inc的净融资为218.87M(同比变化64.36)。
Enliven Therapeutics Inc的每股收益(EPS)是多少?
根据Enliven Therapeutics Inc的FY2025财报,每股收益(EPS)为-1.83(同比变化3.24)。
Enliven Therapeutics Inc的净利润是多少?
根据Enliven Therapeutics Inc的FY2025财报,净利润为-103.69M(同比变化-16.48)。
Enliven Therapeutics Inc的股东权益回报率(ROE)是多少?
根据Enliven Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-26.95(同比变化15.87)。
Enliven Therapeutics Inc的资产回报率(ROA)是多少?
根据Enliven Therapeutics Inc的FY2025财报,资产回报率(ROA)为-25.86(同比变化13.20)。
Enliven Therapeutics Inc的营业利润是多少?
根据Enliven Therapeutics Inc的FY2025财报,营业利润为-119.66M(同比变化-14.45)。